These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 15732531

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Advances in the development of bacterial vector technology.
    Kochi SK, Killeen KP, Ryan US.
    Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rational design of Salmonella recombinant vaccines.
    Cheminay C, Hensel M.
    Int J Med Microbiol; 2008 Jan; 298(1-2):87-98. PubMed ID: 17888730
    [Abstract] [Full Text] [Related]

  • 8. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
    Lewis GK.
    Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
    Phalipon A, Sansonetti P.
    Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Vaccination against the enterobacteria responsible for enteric infections].
    Sansonetti PJ.
    Ann Gastroenterol Hepatol (Paris); 1994 Jun; 30(2):60-3. PubMed ID: 8210205
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG, Balasundaram SV, Janice J, Karnam G, Eswarappa SM, Chakravortty D.
    Vaccine; 2009 May 11; 27(21):2804-11. PubMed ID: 19428891
    [Abstract] [Full Text] [Related]

  • 15. Bivalent vaccines against bacterial enteropathogens: construction of live attenuated vaccine strains with two O-serotype specificities.
    Viret JF, Favre D.
    Biologicals; 1994 Dec 11; 22(4):361-72. PubMed ID: 7540016
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Live bacteria as the basis for immunotherapies against cancer.
    Chabalgoity JA, Dougan G, Mastroeni P, Aspinall RJ.
    Expert Rev Vaccines; 2002 Dec 11; 1(4):495-505. PubMed ID: 12901588
    [Abstract] [Full Text] [Related]

  • 18. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.
    Brockstedt DG, Dubensky TW.
    Expert Rev Vaccines; 2008 Sep 11; 7(7):1069-84. PubMed ID: 18767955
    [Abstract] [Full Text] [Related]

  • 19. Future vaccines against enteric pathogens.
    Levine MM, Edelman R.
    Infect Dis Clin North Am; 1990 Mar 11; 4(1):105-21. PubMed ID: 2155260
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
    Husseiny MI, Hensel M.
    Vaccine; 2009 Jun 08; 27(28):3780-7. PubMed ID: 19464562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.